New ProEducar’s 113 Newsletter

The new ProEducar Educational Newsletter is out for all fellows, interventional trainees, and specialists in hemodynamics seeking to be up to date in their professional practice.

ProEducar Oclusión Total Crónica

This is a special issue on chronic total occlusion (CTO), one of the main current challenges for interventional cardiologists. This comprehensive, extensive work directed by Dr. Gustavo Pedernera includes review articles, relevant clinical cases, interviews to experts, and step-by-step techniques developed by world-renowned Latin American interventional cardiologists.

The newsletter encompasses from revascularization indications to complex revascularization techniques.

Dr. Mario Araya and Dr. Christian Backhouse Q. summarize revascularization indications, and Dr. Marcelo Abud comments on one of the latest articles on current evidence and the benefits of CTO PCI.


Read also | ProEducar’s Newsletter 112: Bifurcations.


The technical focus includes the implementation of a hybrid algorithm assessment, by Dr. Antonio Carlos Botelho and Dr. Alexandre Schaan de Quadros, antegrade approach with wire escalation, by Dr. Carlos Uribe and Dr. Mauricio Zuñiga, dissection and re-entry, by Dr. Ricardo Santiago, and retrograde approach, by Dr. João Tinoco de Paula. These techniques are illustrated through a very challenging clinical case featuring an excellent resolution, by Dr. Andrés Navarro.

Then, Dr. De La Torre summarizes occasional complications and their management.

Finally, there is an interview to Dr. Lucio Padilla on pivotal points for the emergence of a CTO revascularization program and future perspectives in Latin America.


Read also | ProEducar’s Newsletter 111: Unresolved Issues in TAVI.


The ProEducar Newsletter is the result of joint efforts driven by SOLACI and fostered by many Latin American interventional cardiologists who contribute to building a permanent training program for all professionals who want to stay updated and perfect their knowledge and skills in the field of interventional cardiology.

Discover Newsletter #113HERE


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

How to apply for the SOLACI Research 2025 Grant? Step-by-step explanation video

You can now rewatch the virtual event we held on April 9th, where we thoroughly reviewed the steps to apply for the SOLACI Research...

April 9 – How to Apply for the SOLACI Research Grant 2025? Virtual Zoom Event

The Latin American Society of Interventional Cardiology invites you to a new virtual event hosted by the SOLACI Research Department, aimed at clarifying doubts,...

Watch our event on Evidence and Controversies of Renal Denervation in 2025

You can now watch our event, held in collaboration with Medtronic, titled "Evidence and Controversies of Renal Denervation in 2025." The event featured international experts...

March 26 – SOLACI Webinar: Evidence and Controversies in Renal Denervation in 2025

The Latin American Society of Interventional Cardiology invites you to a new virtual event supported by Medtronic. On this occasion, we will hold a 60-minute...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...